SEC Form 4 · accession 0001493152-18-001772
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Punit Dhillon
Officer — President · Director
Period of report
Feb 8, 2018
Accepted (ET)
Feb 9, 2018 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $1.64 | Feb 8, 2018 | A | 300,000 | A | Mar 8, 2018 | Feb 8, 2028 | Common Stock | 300,000 | 1,114,583 | D |
| Restricted Stock UnitsF2,F3 | — | Feb 8, 2018 | A | 200,000 | A | Mar 8, 2018 | Feb 8, 2028 | Common Stock | 200,000 | 475,583 | D |
Explanation of responses
- F125% vested on the Grant Date, and the remaining 75% to vest in 36 equal monthly increments, beginning on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan.
- F2Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F3Pursuant to the Amended and Restated Executive Employment Agreement, dated November 7, 2017, between OncoSec Medical Incorporated and Punit Dhillon, the restricted stock units vest in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan; however, pursuant to a subsequent lock-up agreement related to OncoSec's financing, dated February 1, 2018, vesting is deferred until May 7, 2018.